Clinical Report: Look Again! Demodex Blepharitis in Closer Focus
Overview
Demodex blepharitis (DB) is prevalent in a significant portion of patients, particularly those with ocular surface discomfort. Proper identification and management of DB can improve surgical outcomes and patient satisfaction.
Background
Demodex blepharitis has historically been underappreciated in clinical practice, yet it is increasingly recognized for its impact on ocular health, especially in surgical settings. The condition is associated with a higher prevalence of dry eye disease and can complicate cataract surgery outcomes. Understanding and diagnosing DB is crucial for optimizing patient care.
Data Highlights
{'table': [{'study': 'Lockington et al.', 'findings': 'DB identified in 54% of 804 patients screened.'}, {'study': 'Koetting et al.', 'findings': '69.1% prevalence of dry eye disease in DB patients.'}, {'study': 'Chinese review', 'findings': '89.32% rate of Demodex in patients with meibomian gland dysfunction.'}, {'study': 'Polish study', 'findings': '48% of cataract surgery patients had Demodex.'}, {'study': 'Contact lens study', 'findings': '93% of intolerant users had Demodex infections.'}]}Key Findings
- DB is found in approximately 54% of patients during routine examinations.
- Patients with DB report symptoms like redness, irritation, and itchiness, especially in the upper lids.
- High prevalence of dry eye disease (69.1%) is associated with DB.
- Demodex infestation is prevalent in patients with meibomian gland dysfunction (89.32%).
- Collarettes at the lash base are a key diagnostic sign of DB.
Clinical Implications
Clinicians should incorporate thorough examinations of the upper eyelids to identify DB, especially in patients presenting with ocular discomfort. Effective management of DB can enhance surgical outcomes and reduce postoperative complications.
Conclusion
Demodex blepharitis is a common yet often overlooked condition that can significantly affect ocular health and surgical outcomes. Increased awareness and proper examination techniques are essential for effective diagnosis and management.
References
- Lockington D, Optometric Management, 2023 -- Look Again! Demodex Blepharitis in Closer Focus
- Koetting C, Optometric Management, 2023 -- CLINICAL: Dry Eye
- Stoneback R, Optometric Management, 2023 -- LEADING OFF: Practice Tip: Check the Lids for Demodex Blepharitis
- Yeu E, Corneal Physician, 2021 -- Blepharitis: Know When Demodex is the Culprit
- DEPTH Consensus, PubMed, 2025 -- The Demodex Expert Panel on Treatment and Eyelid Health
- Optometric Management — CLINICAL: Dry Eye
- Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis
- The patient journey and burden of disease in Demodex blepharitis in the United States
- The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.